Drug Search Results
More Filters [+]

Nifuratel

Alternative Names: nifuratel
Latest Update: 2024-03-27
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Bulgaria | Chile | China | Colombia | Croatia | Czech | Hong Kong | Hungary | India | Italy | Lithuania | Mexico | Pakistan | Peru | Poland | Russia | Slovakia | Taiwan | Turkey | Ukraine | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: Jiangsu Zhengrui Pharmaceutical Technology Co., Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Nifuratel

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Trichomonas Infections

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

CTR20243128

N/A

Unknown

Candidiasis, Vulvovaginal

None

CTR20232737

P3

Unknown Status

Trichomonas Infections

None

Recent News Events